Skip to content

Optimer®: Accelerating your journey to clinic

Speeding project timelines can be vital to the development of any life science product. Optimer offers an antibody alternative that can cut as much 75% (2.8 years) off the time to clinic, compared to standard antibodies, helping you bring diagnostic and therapeutic solutions to market faster.
Find out how Optimer compare to antibodies, to deliver:

  • A faster path to clinic
  • A simpler path to clinic with less room for error
  • A more consistent product for less waste in the product lifecycle
  • The ability to pursue new targets for novel diagnostics and therapeutics
  • Low immunogenic molecules for optimal therapeutic profiles
  • High quality, non-animal derived reagents for adherence to directive 2010/63/EU

Download the whitepaper to find out how you could cut valuable years from discovery and development with Optimer.

Download whitepaper

Start your next project with Aptamer Group

Contact one of our experts today